Microbiota and the Immune System-Actors in the Gastric Cancer Story.
Marek MajewskiPaulina MertowskaSebastian MertowskiKonrad SmolakEwelina GrywalskaKamil TorresPublished in: Cancers (2022)
Gastric cancer remains one of the most commonly diagnosed cancers in the world, with a relatively high mortality rate. Due to the heterogeneous course of the disease, its diagnosis and treatment are limited and difficult, and it is associated with a reduced prognosis for patients. That is why it is so important to understand the mechanisms underlying the development and progression of this cancer, with particular emphasis on the role of risk factors. According to the literature data, risk factors include: changes in the composition of the stomach and intestinal microbiota (microbiological dysbiosis and the participation of Helicobacter pylori ), improper diet, environmental and genetic factors, and disorders of the body's immune homeostasis. Therefore, the aim of this review is to systematize the knowledge on the influence of human microbiota dysbiosis on the development and progression of gastric cancer, with particular emphasis on the role of the immune system in this process.
Keyphrases
- risk factors
- helicobacter pylori
- end stage renal disease
- helicobacter pylori infection
- ejection fraction
- endothelial cells
- physical activity
- newly diagnosed
- chronic kidney disease
- systematic review
- healthcare
- papillary thyroid
- genome wide
- electronic health record
- weight loss
- cardiovascular disease
- gene expression
- type diabetes
- young adults
- squamous cell
- climate change
- squamous cell carcinoma
- human health
- pluripotent stem cells
- patient reported
- data analysis
- deep learning